|
|
Volumn 57, Issue 11, 2002, Pages 771-773
|
|
Spironolactone: Is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients?
a a a a a a a |
|
Author keywords
Amphotericin B; Hypokalemia; Spironolactone
|
|
Indexed keywords
AMPHOTERICIN B;
POTASSIUM;
SPIRONOLACTONE;
ARTICLE;
CANCER PATIENT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG MECHANISM;
HEMATOLOGIC DISEASE;
HUMAN;
HYPOKALEMIA;
MYCOSIS;
NEUTROPENIA;
NUTRITIONAL REQUIREMENT;
POTASSIUM BLOOD LEVEL;
POTASSIUM URINE LEVEL;
PRIORITY JOURNAL;
PROPHYLAXIS;
RANDOMIZED CONTROLLED TRIAL;
SUPPLEMENTATION;
ALDOSTERONE ANTAGONISTS;
AMPHOTERICIN B;
ANTIBIOTICS, ANTIFUNGAL;
HUMANS;
HYPOKALEMIA;
KIDNEY FUNCTION TESTS;
MYCOSES;
NEOPLASMS;
NEUTROPENIA;
POTASSIUM;
SPIRONOLACTONE;
|
|
EID: 0035709414
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s00228-001-0390-9 Document Type: Article |
|
Times cited : (17)
|
|
References (16)
|
